Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCCQingbin Liu, Shulong Jiang, Ruikun Qian et al.|Hepatology|2024Cited by 60
Reversal of sorafenib resistance in hepatocellular carcinoma by curcumol: insights from network pharmacology, molecular docking, and experimental validationNi Zhang, Qingbin Liu, Jiaqi Zhang et al.|Frontiers in Pharmacology|2025Cited by 4